Latest Neuroprotection Stories
LOS ANGELES, July 16 /PRNewswire/ -- Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease.
HONG KONG, July 12 /PRNewswire-FirstCall/ - AlphaRx, Inc. (OTCBB: ALRX) announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke.
Scientists have discovered a compound that restores the capacity to form new memories in aging rats, likely by improving the survival of newborn neurons in the brain's memory hub.
RICHMOND, Calif., July 1 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that it has been awarded a second round of funding by The Michael J.
FREMONT, Calif., June 28 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof.
FREMONT, Calif., June 24 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that two of its siRNA drug candidates were featured in the following two presentations at the Glaucoma & Retinopathies 2010 conference, which was held June 21-22, 2010 in London, UK: "QPI-1007, an ocular neuroprotective siRNA for ameliorating RGC (retinal ganglion cell) loss," presented by Elena Feinstein, Chief Scientific...
JACKSONVILLE, Fla., May 24 /PRNewswire/ -- Sinapis Pharma, Inc. has successfully completed a Bridge financing to continue to support its drug development program.
Researchers explore potential benefits of caffeine in special supplement to the Journal of Alzheimer's Disease.
LONDON, May 11, 2010 /PRNewswire/ -- The subject of extensive studies across the world, Resveratrol is proving to be a major talking point in the scientific community.
NEW YORK, April 23 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced more than $3 million in previously unannounced awards ending the first quarter of 2010.
- An armed gangster.